HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hui Xiong Selected Research

type 2E Limb-girdle muscular dystrophy

1/2019Clinical and genetic spectrum of sarcoglycanopathies in a large cohort of Chinese patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hui Xiong Research Topics

Disease

46Neoplasms (Cancer)
09/2022 - 01/2005
10Inflammation (Inflammations)
01/2022 - 10/2013
10Seizures (Absence Seizure)
02/2016 - 09/2007
7Muscular Dystrophies (Muscular Dystrophy)
01/2021 - 12/2006
6Muscular Diseases (Myopathy)
01/2022 - 02/2014
6Breast Neoplasms (Breast Cancer)
01/2022 - 11/2017
6Autosomal Dominant Polycystic Kidney (ADPKD)
01/2022 - 07/2018
6Neoplasm Metastasis (Metastasis)
02/2021 - 10/2012
6Hepatocellular Carcinoma (Hepatoma)
03/2020 - 05/2008
5Alzheimer Disease (Alzheimer's Disease)
09/2022 - 01/2013
5Coronary Artery Disease (Coronary Atherosclerosis)
02/2022 - 02/2011
5Psoriasis (Pustulosis Palmaris et Plantaris)
01/2022 - 01/2015
5Body Weight (Weight, Body)
01/2020 - 08/2014
5Type 2 Diabetes Mellitus (MODY)
01/2019 - 10/2013
5Walker-Warburg Syndrome
01/2017 - 12/2006
5Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked)
06/2011 - 10/2003
4Lung Neoplasms (Lung Cancer)
05/2022 - 11/2018
4Hemorrhage
02/2022 - 01/2010
4Myocardial Infarction
02/2022 - 01/2010
4Adenocarcinoma of Lung
01/2022 - 04/2013
4Carcinogenesis
10/2021 - 01/2005
4Insulin Resistance
12/2020 - 01/2017
4Demyelinating Diseases (Demyelinating Disease)
02/2019 - 05/2005
4Status Epilepticus (Complex Partial Status Epilepticus)
09/2014 - 10/2008
3Acute Kidney Injury (Acute Renal Failure)
02/2022 - 05/2014
3Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 11/2014
3Autoimmune Diseases (Autoimmune Disease)
01/2022 - 01/2015
3Spinal Muscular Atrophy (Progressive Muscular Atrophy)
01/2022 - 06/2011
3Infections
10/2021 - 01/2019
3Leukemia
04/2021 - 12/2003
3Arthritis (Polyarthritis)
04/2021 - 05/2018
3Prostatic Neoplasms (Prostate Cancer)
04/2021 - 02/2006
3Heart Arrest (Cardiac Arrest)
11/2020 - 11/2017
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2020 - 01/2013
3Neuroblastoma
09/2019 - 03/2009
3Cognitive Dysfunction
01/2019 - 03/2017
3Schizophrenia (Dementia Praecox)
01/2018 - 01/2013
3Melanoma (Melanoma, Malignant)
11/2017 - 10/2012
3Chronic Hepatitis B
03/2015 - 03/2010
2Liver Diseases (Liver Disease)
01/2022 - 05/2008
2Heart Diseases (Heart Disease)
11/2021 - 01/2016
2Hyperplasia
06/2021 - 07/2014
2Acquired Immunodeficiency Syndrome (AIDS)
06/2021 - 07/2020
2Candidiasis (Moniliasis)
06/2021 - 07/2020
2Allergic Contact Dermatitis
05/2021 - 01/2019

Drug/Important Bio-Agent (IBA)

17Pharmaceutical PreparationsIBA
01/2021 - 12/2003
16Proteins (Proteins, Gene)FDA Link
09/2022 - 08/2005
10Biological ProductsIBA
03/2022 - 12/2003
8Therapeutic UsesIBA
05/2021 - 09/2014
7Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
10/2019 - 04/2015
7Doxorubicin (Adriamycin)FDA LinkGeneric
10/2019 - 04/2015
7Anticonvulsants (Antiepileptic Drugs)IBA
02/2019 - 10/2008
6LipidsIBA
09/2022 - 02/2012
6Biomarkers (Surrogate Marker)IBA
03/2022 - 05/2018
6CytokinesIBA
05/2021 - 11/2015
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2022 - 11/2018
4Interleukin-6 (Interleukin 6)IBA
05/2021 - 10/2013
4AcidsIBA
01/2020 - 04/2003
3ErbB Receptors (EGF Receptor)IBA
05/2022 - 04/2013
3AntibodiesIBA
01/2022 - 06/2011
3InterferonsIBA
01/2022 - 01/2020
3Bile Acids and Salts (Bile Acids)IBA
01/2022 - 10/2014
3IronIBA
01/2022 - 10/2019
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 10/2013
3VaccinesIBA
09/2021 - 09/2014
3Dystroglycans (Dystroglycan)IBA
01/2021 - 12/2006
3Imiquimod (Aldara)FDA LinkGeneric
10/2020 - 01/2015
3Phosphotransferases (Kinase)IBA
01/2020 - 06/2006
3Fatty Acids (Saturated Fatty Acids)IBA
01/2020 - 05/2005
3N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
02/2019 - 01/2014
3Laminin (Merosin)IBA
10/2018 - 12/2006
3Blood Glucose (Blood Sugar)IBA
01/2018 - 01/2017
3Glucose (Dextrose)FDA LinkGeneric
01/2018 - 01/2017
3Insulin (Novolin)FDA Link
01/2018 - 01/2017
3Messenger RNA (mRNA)IBA
12/2017 - 05/2016
3protein O-mannose beta-1,2-N-acetylglucosaminyltransferaseIBA
01/2017 - 10/2011
3Hypoglycemic Agents (Hypoglycemics)IBA
01/2017 - 10/2013
3EnzymesIBA
06/2015 - 02/2011
3NucleotidesIBA
03/2015 - 02/2007
3DNA (Deoxyribonucleic Acid)IBA
03/2010 - 03/2007
3Adrenocorticotropic Hormone (ACTH)FDA Link
11/2008 - 02/2006
3Endothelin-1 (Endothelin 1)IBA
02/2006 - 01/2005
2SugarsIBA
09/2022 - 01/2019
2Tyrosine Kinase InhibitorsIBA
05/2022 - 01/2019
2AntigensIBA
03/2022 - 01/2020
2Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
01/2022 - 10/2014
2Cholinergic ReceptorsIBA
01/2022 - 06/2011
2Oxygen (Dioxygen)IBA
12/2021 - 01/2021
2Circular RNAIBA
11/2021 - 11/2021

Therapy/Procedure

24Therapeutics
09/2022 - 05/2002
8Drug Therapy (Chemotherapy)
09/2022 - 04/2015
5Off-Pump Coronary Artery Bypass (Coronary Artery Bypass, Off Pump)
02/2022 - 02/2011
3Aftercare (After-Treatment)
09/2022 - 09/2014
3Percutaneous Coronary Intervention
02/2022 - 02/2013
3Immunotherapy
01/2021 - 01/2019
3Tibetan Traditional Medicine (Traditional Tibetan Medicine)
04/2019 - 01/2017
3Coronary Artery Bypass (Coronary Artery Bypass Surgery)
08/2014 - 02/2013
2Sutures (Suture)
05/2022 - 01/2021
2Blood Transfusion (Blood Transfusions)
02/2022 - 05/2014
2Highly Active Antiretroviral Therapy (HAART)
06/2021 - 07/2020